Ilan Daskal
CIK 1446964 · EVP, CFO · last filed 2026-09-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VIAV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HERCULES, CA 94547
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIAV | EVP, CFO | 55,518 | $31.88 | $1.77M | -$5.78M | 12 | 2026-09-23 |
| BIO.B | EVP, Chief Financial Officer | 2,206 | $364.15 | $803.4K | -$2.40M | 12 | 2023-09-06 |
| NATUS MEDICAL INC (NTUS) Delisted | Director | 0 | $32.96 | $0 | -$68.7K | 6 | 2022-07-21 |
| IXIA (XXIA) Delisted | Director | 16,140 | — | — | $0 | 2 | 2016-06-07 |
| SUNE | EVP & CFO Designee | 2,000 | $1.99 | $4.0K | $0 | 1 | 2016-04-11 |
| CEPHEID (CPHD) Delisted | EVP, Chief Financial Officer | 10,000 | — | — | $0 | 1 | 2015-04-13 |
| INTERNATIONAL RECTIFIER CORP /DE/ (IRF) Delisted | Executive Vice President & CFO | 0 | — | — | -$3.88M | 33 | 2015-01-13 |
Recent Filings · Page 4 of 8
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-09 | BIO.B | Mixed | +457 | -$97.9K | EDGAR |
| 2020-03-20 | NATUS MEDICAL INC (NTUS) Delisted | Grant (A) | +7,588 | $150.0K | EDGAR |
| 2019-04-09 | BIO.B | Grant (A) | — | $0 | EDGAR |
| 2017-04-20 | — | Disp (D) | −16,140 | -$317.2K | |
| 2016-06-07 | IXIA (XXIA) Delisted | Grant (A) | +9,709 | $0 | EDGAR |
| 2016-04-11 | SUNE | Grant (A) | +400,000 | $144.0K | EDGAR |
| 2015-08-11 | IXIA (XXIA) Delisted | Grant (A) | +6,431 | $0 | EDGAR |
| 2015-04-13 | CEPHEID (CPHD) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2015-01-13 | INTERNATIONAL RECTIFIER CORP /DE/ (IRF) Delisted | Disp (D) | −17,357 | -$694.3K | EDGAR |
| 2013-08-27 | INTERNATIONAL RECTIFIER CORP /DE/ (IRF) Delisted | Sell (S) | −20,475 | -$507.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.